BSE filing, NSE: TTKPRESTIG. Summary written from the filing by ALFA Finder's alert engine.
TTK Prestige Ltd: key numbers
- Share price
- ₹532.50
- Market cap
- ₹7,294 Cr
- Revenue (annual)
- ₹2,974 Cr
- Net profit (annual)
- ₹160.6 Cr
- P/E (TTM)
- 42.7×Sector 41.7×
- Promoter holding
- 70.51%-0.01% QoQ
- FII holding
- 7.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TTK Prestige Ltd
All →TTK Prestige Business Update
TTK Prestige redeemed its entire CCD investment in GramyaHaat Rural-Tech made in June 2024. The redemption resulted in a non-material loss with no impact on financial position.
TTK Prestige Employee Stock Options
TTK Prestige Limited allotted 685 equity shares at Rs. 1 each following the exercise of employee stock options. This allotment increases the company's paid-up equity capital to Rs. 13,69,67,069.
TTK Prestige Merger & Restructuring
TTK Prestige has completed the sale of its 51% stake in subsidiary Ultrafresh Modular Solutions to EFC (I) Limited. Ultrafresh ceases to be a subsidiary.
TTK Prestige Board Meeting Date
TTK Prestige will hold a board meeting on November 06, 2026, to approve its financial results for the quarter ended September 30, 2026.
TTK Prestige Management Change
TTK Prestige appointed Mr. R Srinivasan as Non-Executive Non-Independent Director effective 10 September 2026. He was reappointed following retirement by rotation at the 70th AGM, approved via postal ballot.
TTK Prestige Annual General Meeting
TTK Prestige shareholders passed a postal ballot appointing Mr. R. Srinivasan as Non-Executive Non-Independent Director. Resolution secured 99.97% favourable votes on September 10, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.